Treatment of hepatitis C in hemophiliacs

American Journal of Hematology

Volumn 81, Issue 9, 2006, Pages 696-702

  Franchini, Massimo ^a,c   Nicolini, Nicoletta ^b   Capra, Franco ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c OSPEDALE POLICLINICO   (Italy)

Author keywords

Clotting factor; Combination therapy; HCV; Infection

Indexed keywords

ANTIRETROVIRUS AGENT; BLOOD CLOTTING FACTOR CONCENTRATE; INTERFERON; PEGINTERFERON; RIBAVIRIN;

ADULT; BACTERIAL INFECTION; CLINICAL ARTICLE; COMORBIDITY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CARCINOMA; LIVER FAILURE; MALE; MONOTHERAPY; PRIORITY JOURNAL; SHORT SURVEY; VIRUS TRANSMISSION;

DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEMOPHILIA A; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON TYPE I, RECOMBINANT; LIVER TRANSPLANTATION; RIBAVIRIN; TREATMENT OUTCOME;

EID: 33748098892     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20701     Document Type: Short Survey

References (63)

1. Fried MW. Management of hepatitis C in the hemophilia patient. Am J Med 1999;107:85-89.
2. Lee CA. Hepatitis C infection and its management. Haemophilia 2000;6:133-137.
3. Franchini M, Rossetti G, Tagliaferri A, et al. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001;98:1836-1841.
4. Makris M, Preston FE, Triger DR, et al. Hepatitis C antibody and chronic liver disease in hemophilia. Lancet 1990;335:1117-1119.
5. Troisi CL, Hollinger FB, Hoots WK, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993;81:412-418.
6. Franchini M, Capra F, Tagliaferri A, et al. Update on chronic hepatitis C in hemophiliacs. Haematologica 2002;87:542-549.
7. Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR. The natural history of chronic hepatitis C in hemophiliacs. Br J Haematol 1996;94:746-752.
8. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of hemophilic patients. Br J Haematol 1994;87:555-561.
9. Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of hemophilic patients infected between 1961 and 1985. Gut 2000;47:845-851.
10. Meijer K, Haagsma EB, Kok T, Schirm J, Smid WM, van der Meer J. Natural history of hepatitis C in HIV-negative patients with congenital coagulation disorders. J Hepatol 1999;31:400-406.
11. Franchini M. Hepatitis C in haemophiliacs. Thromb Haemost 2004;92:1259-1268.
12. Meijer K, Smid WM, van der Meer J. Treatment of chronic hepatitis C in haemophilia patients. Haemophilia 2000;6:605-613.
13. Dusheiko GM. Therapy for chronic hepatitis B and C infection in haemophilia. Haemophilia 1998;4:577-586.
14. Makris M, Preston FE, Triger DR, Underwood JCE, Westlake L, Adelman MI. A randomized controlled trial of recombinant interferon-α in chronic hepatitis C in hemophiliacs. Blood 1991;78:1672-1677.
15. Adamowicz-Salach A, Pawelec K, et al. Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland. Haemophilia 1999;5:436-440.
16. Telfer P, Devereux H, Colvin B, et al. Alpha interferon for hepatitis C virus infection in haemophilic patients. Haemophilia 1995;1:54-58.
17. Hanley JP, Jarvis LM, Andrews J, et al. Interferon treatment for chronic hepatitis C infection in hemophiliacs-influence of virus load, genotype and liver pathology on response. Blood 1996;87:1704-1709.
18. Peerlink K, Wilems M, Sheng L, et al. Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment. Br J Haematol 1994;86:816-819.
19. Laursen AL, Scheibel E, Ingerslev J, et al. Alpha interferon therapy in Danish haemophiliac patients with chronic hepatitis C: results of a randomized controlled open label study comparing two different maintenance regimens following standard interferon-alpha-2b treatment. Haemophilia 1998;4:25-32.
20. Beurton I, Bertrand MA, Bresson-Hadni S, et al. Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patients. Eur J Gastroenterol Hepatol 2001;13:859-864.
21. Yoshikawa M, Fukui H, Kojima H, et al. Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan. J Gastroenterol 1995;30:367-371.
22. Bresters D, Mauser-Bunschoten EP, Cuypers HT, et al. Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients. Gut34(Suppl 2):S124-S125, 1993.
23. Mauser-Bunschoten EP, Bresters D, Reesink HW, et al. Effect and side-effect of alpha interferon treatment in haemophilia patients with chronic hepatitis C. Haemophilia 1995;1:45-53.
24. Yamada M, Fukuda Y, Koyama Y, et al. A long-term follow up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders. Eur J Haematol 1996;57:165-170.
25. Pinilla J, Quintana M, Magallon M. High-dose and long-term therapy of α-interferon in hemophilic patients with chronic C virus hepatitis. Blood 1998;9:727-728.
26. Hayashi K, Fukuda Y, Nakano I. Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs. Haemophilia 2000;6:677-681.
27. Rumi MG, Santagostino E, Morfini M, et al. A multicenter controlled, randomized, open trial of interferon α2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Blood 1997;89:3529-3533.
28. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
29. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-1432.
30. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493-1499.
31. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl Med 1998;339:1485-1492.
32. Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnenborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:83-87.
33. Makris M, Baglin G, Dusheiko G, et al. Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. Haemophilia 2001;7:339-345.
34. Shields PL, Mutimer DJ, Muir D, et al. Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders. Br J Haematol 2000;108:254-258.
35. Sauleda S, Esteban JI, Altisen C, Puig L, Esteban R, Guardia J. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C. Thromb Haemost 2000;83:807-810.
36. Lethagen S, Widell A, Berntorp E, Verbaan H, Lindgren S. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease. Br J Haematol 2001;113:87-93.
37. Schulman S, Kinnmann N, Lindmarker P, von Sydow M. A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders. Haemophilia 2002;8:129-135.
38. Fried MW, Peter J, Hoots K, et al. Hepatitis C in adults and adolescents with haemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin. Hepatology 2002;36:967-972.
39. Santagostino E, De Filippi F, Rumi MG, Rivi M, Colombo M, Mannucci PM, for the Hepatitis Study Group of the Association of Italian Hemophilia Centers. Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients. Transfusion 2004;44:790-794.
40. Santagostino E, Rumi MG, Rivi M, Colombo M, Mannucci PM, for the Hepatitis Study Group of the Association of Italian Hemophilia Centers. Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy. Blood 2002;99:1089-1091.
41. Franchini M, Tagliaferri A, Rossetti G, et al. Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment. Haemophilia 2002;8:794-797.
42. Puetz J, Thrower M. Kane R, Bouhasin J. Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center. Haemophilia 2004;10:87-93.
43. Meijer K, Haagsma EB, van der Meer J. CHARIBDIS Study Group. A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia. J Thromb Haemost 2004;2:194-196,
44. Heathcote EJ, Shiffman ML, Cooksley WG, et al. Peginterferon α-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000;343:1673-1680.
45. Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon α-2a in patients with chronic hepatitis C. N Engl J Med 2000;343:1666-1672.
46. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-965.
47. Mancuso ME, Santagostino E, Linari S, et al. Sustained suppression of hepatitis C by pegylated interferon (pegIFN) and ribavirin in hemophilic patients. Haemophilia 2004;10(Suppl 1):48.
48. Husa P, Smejkal P, Husova L, Penka M. Treatment of chronic hepatitis C in hemophilic patients. Acta Virol 2004;48:35-38.
49. Wilde JT. HIV and HCV coinfection in haemophilia. Haemophilia 2004;10:1-8.
50. Soriano V, Rodriguez-Rosado R, Garcia-Samaniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS 1999;13:539-546.
51. Soriano V, Miró JM, García-Samaniego J, et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hep 2004;11:2-17.
52. Soriano V, Puoti M, Sulkowski M, et al. Care of patients with hepatitis C and HIV co-infection. AIDS 2004;18:1-12.
53. Hanabusa H. Efficacy of induction therapy with high-dose interferon for patients with hemophilia and human immunodeficiency virus-hepatitis C virus coinfection. Clin Infect Dis 2002;35:1527-1533.
54. Theodossiades G, Nomikou E, Tsevrenis V, et al. Treatment with peg-interferon α-2b and ribavirin in patients with congenital hemorrhagic disorders and HCV infection. Haemophilia 2004;10(Suppl 1):50.
55. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl Med 1996;334:815-820.
56. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999;117:619-625.
57. Lewis JH, Bontempo FA, Spero JA, et al. Liver transplantation in a hemophiliac. N Engl J Med 1985;312:1189-1190.
58. Bontempo FA, Lewis JH, Gorenc TJ, et al. Liver transplantation in hemophilia A. Blood 1987;69:1721-1724.
59. Ragni MV, Dodson SF, Hunt SC, Bontempo FA, Fung JJ. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood 1999;93:1113-1114.
60. Baudo F, Caimi TM, Redaelli R, et al. Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis. Haemophilia 1999;5:276-277.
61. Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998;42:744-749.
62. Wilde J, Teixeira P, Bramhall SR, Gunson B, Mutimer D, Mirza DF. Liver transplantation in haemophilia. Br J Haematol 2002;117:952-956.
63. Santagostino E, Colombo M, Rivi M, et al. Study Group of the Association of Italian Hemophilia Centers. A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood 2003;102:78-82.